Effect of the farnesoid X receptor agonist, obeticholic acid, in hepatocellular carcinoma: Is it NASH-dependent or -independent?

被引：1
|
作者：
Attia, Yasmeen [1 ]
Tawfiq, Rasha [1 ]
Adel, Aya [1 ]
Gibriel, Abdullah [2 ]
Hammam, Olfat [3 ]
Elmazar, Mohamed [1 ]
机构：
[1] British Univ Egypt, Dept Pharmacol, Cairo, Egypt
[2] British Univ Egypt, Dept Biochem, Cairo, Egypt
[3] Theodor Bilharz Res Inst, Dept Pathol, Cairo, Egypt
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31027-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-282
引用
收藏
页码：E520 / E520
页数：1
相关论文
共 50 条
  • [21] THE POTENTIAL EFFECT OF COMBINATION THERAPIES WITH A FARNESOID X RECEPTOR (FXR) AGONIST ON HEPATIC FIBROGENESIS IN RAT NASH MODEL
    Shimozato, Naotaka
    Namisaki, Tadashi
    Kaji, Kosuke
    Takaya, Hiroaki
    Saikawa, Soichiro
    Sawada, Yasuhiko
    Nakanishi, Keisuke
    Furukawa, Masanori
    Fujinaga, Yukihisa
    Kaya, Daisuke
    Tsuji, Yuki
    Kawaratani, Hideto
    Akahane, Takemi
    Yoshiji, Hitoshi
    HEPATOLOGY, 2019, 70 : 1281A - 1282A
  • [22] THE FIRST NEW MONOTHERAPY THERAPEUTIC PBC STUDY IN A DECADE? AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID IN PBC
    Jones, D.
    Kowdley, K.
    Chapman, R.
    Burroughs, A.
    Hirschfield, G.
    Schramm, C.
    Poupon, R.
    ParEs, A.
    Shapiro, D.
    Pruzanski, M.
    GUT, 2011, 60 : A50 - A50
  • [23] Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid
    Meshanni, Jaclynn A.
    Lee, Jordan M.
    Vayas, Kinal N.
    Sun, Rachel
    Jiang, Chenghui
    Guo, Grace L.
    Gow, Andrew J.
    Laskin, Jeffrey D.
    Laskin, Debra L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 388 (02): : 586 - 595
  • [24] A PRELIMINARY STUDY OF THE EFFECTS OF OBETICHOLIC ACID, A FARNESOID X RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC DIARRHOEA SECONDARY TO CROHN'S ILEAL DISEASE
    Nolan, J. D.
    Vassie, C.
    Johnston, I. M.
    Shapiro, D.
    Walters, J. R.
    GUT, 2014, 63 : A258 - A258
  • [25] THE FIRST NEW MONOTHERAPY THERAPEUTIC PBC STUDY IN A DECADE? AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID IN PBC
    Kowdley, Kris V.
    Luketic, Velimir A.
    Jones, David E.
    Chapman, Roger W.
    Burroughs, Andrew K.
    Hirschfield, Gideon M.
    Poupon, Raoul
    Schramm, Christoph
    Vincent, Catherine
    Rust, Christian
    Pares, Albert
    Mason, Andrew L.
    Castelloe, Erin N.
    Sciacca, Cathi I.
    Boehm, Olaf
    Pruzanski, Mark
    Shapiro, David A.
    HEPATOLOGY, 2011, 54 : 416A - 417A
  • [26] Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation
    Fujino, Tomofumi
    Takeuchi, Airi
    Maruko-Ohtake, Akiko
    Ohtake, Yosuke
    Satoh, Junichi
    Kobayashi, Tomonori
    Tanaka, Toshiaki
    Ito, Haruka
    Sakamaki, Ryosuke
    Kashimura, Ryo
    Ando, Ken
    Nishimaki-Mogami, Tomoko
    Ohkubo, Yasuhito
    Kitamura, Naomi
    Sato, Ryuichiro
    Kikugawa, Kiyomi
    Hayakawa, Makio
    JOURNAL OF BIOCHEMISTRY, 2012, 152 (06): : 577 - 586
  • [27] Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury
    Zhu, Jin-Bo
    Xu, Shen
    Li, Jun
    Song, Jin
    Luo, Biao
    Song, Ya-Ping
    Zhang, Zhi-Hui
    Chen, Yuan-Hua
    Xie, Dong-Dong
    Yu, De-Xin
    Xu, De-Xiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838 : 60 - 68
  • [28] Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis
    Adorini, Luciano
    Rigbolt, Kristoffer
    Feigh, Michael
    Roth, Jonathan
    Erickson, Mary
    PLOS ONE, 2024, 19 (04):
  • [29] FURTHER INCREASE IN BILIARY EXCRETION OF ASYMMETRIC DIMETHYLARGININE DURING HEPATIC ISCHEMIA/REPERFUSION INJURY BY OBETICHOLIC ACID, A FARNESOID-X-RECEPTOR AGONIST
    Di Pasqua, L. G.
    Berardo, C.
    Rizzo, V.
    Adorini, L.
    Richelmi, P.
    Vairetti, M.
    Ferrigno, A.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E55 - E55
  • [30] A LONG TERM SAFETY EXTENSION TRIAL OF THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) AND UDCA IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Hirschfield, Gideon M.
    Mason, Andrew L.
    Gordon, Stuart C.
    Luketic, Velimir A.
    Mayo, Marlyn
    Vincent, Catherine
    Lindor, Keith D.
    Pares, Albert
    Kowdley, Kris V.
    Trauner, Michael
    Esguerra, Maria
    Boehm, Olaf
    Shapiro, David A.
    HEPATOLOGY, 2011, 54 : 429A - 429A
12345